Combipatch (estradiol/norethindrone Acetate Transdermal System) recalls
Combipatch (estradiol/norethindrone Acetate Transdermal System) products have been recalled 2 times, most recently on 25 Aug 2021. The recalling company is usually Noven Pharmaceuticals. The most common reason is potency & assay.
Total recalls2since 2021
Last 12 months0reported
Class I00% of total
Ongoing2latest 25 Aug 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why combipatch (estradiol/norethindrone acetate transdermal system) is recalled
Companies
Product types
By year
Ongoing combipatch (estradiol/norethindrone acetate transdermal system) recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Combipatch (estradiol/norethindrone acetate transdermal recalledCombipatch (estradiol/norethindrone Acetate Transdermal System) | Noven Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Combipatch (estradiol/norethindrone acetate transdermal recalledCombipatch (estradiol/norethindrone Acetate Transdermal System) | Noven Pharmaceuticals | Potency & Assay | Nationwide |
All combipatch (estradiol/norethindrone acetate transdermal system) recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Combipatch (estradiol/norethindrone acetate transdermal recalledCombipatch (estradiol/norethindrone Acetate Transdermal System) | Noven Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Combipatch (estradiol/norethindrone acetate transdermal recalledCombipatch (estradiol/norethindrone Acetate Transdermal System) | Noven Pharmaceuticals | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.